Taking ashwagandha while on Mounjaro: what the evidence says

Step 1: Understand what each one actually does in the body

Mounjaro works by activating two gut-hormone receptors, GIP and GLP-1, which slow the rate at which food leaves your stomach, reduce appetite and help regulate blood sugar. It is a dual-agonist (the only weight-loss medicine of its kind currently licensed in the UK) and its effects on insulin sensitivity are well-documented in large clinical trials. You can read a full overview of how tirzepatide works on the tirzepatide treatment page.

Ashwagandha (Withania somnifera) is an adaptogenic herb used in Ayurvedic medicine for centuries. Modern studies suggest it may lower cortisol, reduce anxiety, support sleep and (importantly for this question) have modest hypoglycaemic (blood-sugar-lowering) and antihypertensive (blood-pressure-lowering) effects. The NHS does not recommend ashwagandha for any medical condition, and supplement-grade products are not subject to the same purity and dose controls as licensed medicines. This matters when you are already taking a prescription medicine that has its own metabolic effects.

Because tirzepatide and ashwagandha both pull in the same metabolic direction with blood sugar, the concern is not a sudden dangerous crash for most people, it is a cumulative, gradual shift that could go unnoticed, particularly at higher tirzepatide doses or if your ashwagandha product contains more active ingredient than the label suggests.

Step 2: Weigh the specific risks of combining them

A question our prescribers hear most weeks is whether herbal supplements are safe to carry on with during treatment. The honest answer is: it depends on the supplement, the dose, and the individual. With ashwagandha and Mounjaro, three areas deserve attention.

Blood sugar. Some small trials suggest ashwagandha may lower fasting blood glucose, particularly in people with elevated readings. If your prescriber is also monitoring glucose as part of your Mounjaro treatment, adding ashwagandha without telling them makes that picture harder to read. You can find more about how tirzepatide and blood sugar interact on the Mounjaro overview page.

Blood pressure. Animal and limited human studies show ashwagandha may reduce systolic blood pressure modestly. Mounjaro itself can cause a small reduction in blood pressure in some people. If you already take antihypertensive medication, layering ashwagandha on top introduces another variable your prescriber needs to know about.

Gastrointestinal tolerance. Tirzepatide's most common side effects are gastrointestinal: nausea, loose stools, and bloating are all reported, particularly at the start of treatment or after a dose step. Some people also report digestive sensitivity to ashwagandha. Combining the two during the early weeks of Mounjaro treatment may make it harder to work out what is driving any discomfort. If you are curious about the broader GI picture with Mounjaro, the Mounjaro and IBS page covers that territory. The emotional side effects page is worth a look too, given ashwagandha is often taken for stress and mood, it is useful to understand which medicine is doing what.

None of this means ashwagandha is dangerous with Mounjaro. The current evidence does not establish a direct harmful interaction. What it does mean is that your prescriber should know you are taking it, so they can factor it into clinical decisions.

Step 3: What to tell your prescriber (and when)

Before your Mounjaro consultation (whether that is your first or a repeat) list every supplement, including ashwagandha, alongside any prescribed medicines. This is not a bureaucratic formality. It is the information that allows a prescriber to give you a genuinely informed assessment rather than a partial one. The clinical team at nume reviews your full health picture, not just the weight-management box you tick.

If you are already taking Mounjaro and want to add ashwagandha, contact your prescriber first. Do not wait until your next scheduled review. This is particularly true if you take medication for blood pressure, diabetes or thyroid conditions, as ashwagandha has shown potential interactions with thyroid hormone levels in some studies, an important consideration given that thyroid function is part of the eligibility check for tirzepatide treatment. The Mounjaro and HRT page covers a similar question about combining hormonal treatments with tirzepatide, and the same principle applies here: full disclosure to your prescriber is the safest approach.

The nume FAQs cover common questions about what to disclose before treatment. And if cost is a factor in your decision-making around starting Mounjaro, the Mounjaro cost page sets out what private treatment typically involves in terms of pricing in the UK. The about us page explains how our pharmacy is registered and regulated, which is the right question to ask of any online provider.

The NHS patient-level guidance on tirzepatide (including interactions and what to tell your doctor before starting) is published on the NHS tirzepatide medicines page. For supplement interactions specifically, the NHS recommends erring on the side of disclosure. That is good advice here.